Introduction {#s1}
============

Bleeding per rectum is one of the common presenting complaints seen in pediatric clinic. The common differential diagnosis are infectious/allergic colitis, colonic polyps, Inflammatory Bowel Disease (IBD), anal fissure and rare conditions like rectal colopathy, vascular ectasia. Solitary rectal ulcer syndrome (SRUS) is often missed at early clinical presentation due to lack of clinical suspicion and usually diagnosed lately.

SRUS is a benign chronic disorder often related to abnormal defecation or straining during defecation. It was well-recognized in the adult population with an incidence of 1 in 100,000 ([@B1]) and less common in childhood period. Lack of distinct clinical presentation and varying symptomology, diagnosis is often delayed if not suspected. And since it is a masquerader of IBD and polyps, misdiagnosis may lead to treatment disaster and unwanted surgery. Only few case reports and case series have been reported so far in children. We report a series of 24 children with SRUS and their treatment response.

Materials and Methods {#s2}
=====================

Retrospective analysis of case records during the period 2012--2017 was done at Department of Pediatric Gastroenterology, Institute of Child Health, Chennai, India. Histologically confirmed SRUS cases were selected and informations such as demographic profile, clinical presentations, routine investigations (complete hemogram, renal function test, stool, and urine routine) and colonoscopic findings were obtained from medical record department. In addition to this, type of treatment, and its response over follow-up period of 1 year were analyzed.

Results {#s3}
=======

Total number of children with SRUS was 24. The median age of presentation was 8 years ranging between 5 and 12 years with Male to Female ratio of 1:1.1. Intermittent rectal bleeding was the presenting complaint in all cases. Mucorrhea (70.8%) and abdominal pain (58.3%) were the associated symptoms. The median duration from onset of symptoms to diagnosis was 5.5 months (IQR 3.0--7.75) with 70 percent of children had symptoms for \< 6 months duration. Straining at defecation and passage of hard stool was present in 19 (79.1%) and there was a need for digital evacuation in 27% of children. Four children (16.6%) presented with diarrhea. Rectal prolapse was documented in one child. Anemia (Hb \< 10 gm/dl) was most commonly seen in 79.1% of cases. The colonoscopy findings revealed that 11 (45.8%) children had single ulcer in the anterior wall of rectum, another 11 (45.8%) children had multiple ulcers and two children (8.3%) had polypoidal lesion ([Table 1](#T1){ref-type="table"}). Size of ulcers ranged from 0.5 to 4 cm in diameter but majority were 1--1.5 cms in diameter ([Figure 1](#F1){ref-type="fig"}). All the lesions were in rectum and within 5--10 cms from anal verge. Histology finding documented were presence of fibromuscular obliteration in all cases (100%) followed by surface ulceration with minimal inflammation in 22 (92%) and hypertropic muscularis mucosa with splayed fibers in 21 (87.5%) ([Figure 2](#F2){ref-type="fig"}). A mixed inflammatory infiltrate was also encountered in 3 cases, but cryptitis or crypt abscesses and chronic changes characteristic of IBD were not seen in any biopsies.

###### 

Demographic profile, clinical presentation, colonoscopy findings and histological findings (*N* = 24).

  **Characteristics**                                                           **N (%)**
  ----------------------------------------------------------------------------- ----------------------------
  **Demographic profile**                                                       
  Median age of presentation                                                    8 years (IQR 5.75--11)
  Male: Female ratio                                                            1:1.1
  **Clinical presentation**                                                     
  Median duration of symptoms                                                   5.5 months (IQR 3.0--7.75)
  Rectal Bleeding                                                               24 (100)
  Straining during defecation                                                   19 (79.1)
  Mucorrhea                                                                     17 (70.8)
  Abdominal pain                                                                14 (58.3)
  Rectal Prolapse                                                               1 (4.2)
  **Stool consistency**                                                         
  Hard stool                                                                    19 (79.1)
  Loose stool                                                                   4 (16.6)
  Digital evacuation                                                            6 (25)
  Anemia                                                                        19 (79.1)
  **Colonoscopy findings**                                                      
  Single ulcer                                                                  11 (45.8)
  Multiple ulcer                                                                11 (45.8)
  Polypoidal lesion                                                             2 (8.3)
  **Histological findings**                                                     
  Fibromuscular obliteration of the lamina propria                              24 (100)
  Surface ulceration with minimal inflammation                                  22 (91.6)
  Hypertrophic muscularis mucosa with splayed fibers                            21 (87.5)
  Mixed inflammatory infiltrate with branching and distorted glandular crypts   3 (12.5)
  Cryptitis or crypt abscesses and chronic changes                              0

*IQR, Inter-Quartile Range*.

![Colonoscopic Findings in SRUS: **(A)** Polypoidal mass like lesion. **(B)** Well-demarcated ulcer in rectum.](fped-08-00396-g0001){#F1}

![Histology (H & E) Findings in SRUS. **(A)** Complete ulceration of lining mucosa. **(B)** Obliteration of the lamina propria by fibromuscular proliferation of the muscularis mucosa admitting with few inflammatory cell composed of lymphocytes and plasma cells.](fped-08-00396-g0002){#F2}

All children with constipation were treated with dietary fibers (age in years + 5 g per day), toilet training and followed by laxatives like Polyethylene glycol---PEG 3,350 (0.5--1 g/kg once daily) or Lactulose (1 ml/kg twice daily initially then titrated to achieve 2 soft stools per day) or Liquid paraffin 1 ml/kg/day oral solution for 4--8 weeks. Parents were reassured of the benign nature of the disease and need for regular toilet habits to prevent relapses. About 18 children out of 24 (75%) responded to above treatment and maintained remission till the follow up period of 1 year. Six children (25%) had recurrent rectal bleeding and were treated with corticosteroid rectal enema for 5--7 days. One child had profuse recurrent rectal bleeding despite medical therapy and was referred to higher center for Argon Plasma coagulation. But the child was lost to follow-up. None of our children required surgery ([Table 2](#T2){ref-type="table"}).

###### 

Treatments and its response (*N* = 24).

  **Treatment**                                                                                     **Response N (%) (Follow-up of 1 year)**
  ------------------------------------------------------------------------------------------------- ------------------------------------------
  **Conventional treatment**                                                                        **(*****N*** **=** **24)**
  Toilet Training and High Fiber Diet: ≥ (Age in yrs + 5) gms ± Osmotic Laxatives/Stool softeners   Remission 18 (75) Relapse 6 (25)
  {PEG(0.5--1 gm/kg OD) or Lactulose (1 ml/kg BD) or Liquid Paraffin (1 ml/kg OD) per oral}         
  **Other treatments**                                                                              **(*****N*** **=** **6)**
  Rectal Steroid enema                                                                              Remission 5 (83.3)
                                                                                                    Failure 1 (16.7)
  Argon Plasma Coagulation(1 child)                                                                 Lost to follow up (1)

Discussion {#s4}
==========

In the year 1829, Cruveilhier ([@B2]) had reported four unusual cases of rectal ulcers. Lloyd-Davis used the term "solitary ulcers of the rectum" in the late 1930s. The disease became widely recognized after a review of 68 cases by Madigan et al. ([@B3]) Later, Rutter et al. ([@B4]) also reported the detailed pathogenic concept of the disease. Solitary rectal ulcer is a misnomer since only 40% of patients had ulcer and others presentations were hyperemic mucosa to broad-based polypoidal lesions. Lesions may be of varying size and shape and ulcer may be solitary or multiple ([@B5]) and may involve sigmoid colon also.

High index of clinical suspicion is needed and diagnosis is based on symptomatology in combination with endoscopic and histological findings. The pathophysiology of SRUS is incompletely understood. Inappropriate contraction of the puborectalis muscle, chronic mechanical, and ischemic trauma, inflammation by hard stools and rectal mucosal prolapse have been commonly implicated ([@B6]).

In the present study, majority (75%) of children were aged more than 5 years at the time of presentation as comparable with other cases series ([@B7]--[@B9]) and youngest patient in our study was 1.5 years. Our series observed slight female predominance in contrast to Suresh et al. ([@B7]) and Kennedy et al. ([@B10]).

Intermittent rectal bleeding and/or mucorrhea were the commonest presentation similar to other reported series ([@B7], [@B11]--[@B15]) Predisposing factors for SRUS like constipation (hard stool), straining during defecation were present in majority of case series ([@B7], [@B12], [@B14]--[@B16]). The other presenting symptom which signifies rectal diseases like tenesmus, rectal prolapse were present in varying proportions ([@B7], [@B12], [@B14]--[@B17]). One of the importance and significant observation was that median time interval between onset of index symptoms to diagnosis was 5.5 months in our study series whereas, it was found to be ranging from 6 months to 3.2 years in the other series reviewed ([Table 3](#T3){ref-type="table"}). The reason for our early diagnosis may be due to early clinical suspicion and evaluation for SRUS earliest at after ruling out common causes. Clinical symptoms in favor of SRUS were features of dyssynergic defecation such as straining during defecation, hard stool, sensation of incomplete evacuation, and digital evacuation.

###### 

Summary of case series reported in literature over past 20 years.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Case series**               ***N***   **Age in years**               **Duration from symptoms to diagnosis**   **Symptoms**          **Colonoscopic finding**   **Treatment given**                **Outcomes**
  ----------------------------- --------- ------------------------------ ----------------------------------------- --------------------- -------------------------- ---------------------------------- -------------------------
  Godbole et al. ([@B18])       2         Mean: 13 ± 1                   2--5 years                                RP, RB                U, Po                      R                                  Remission (2)

  Kiristioglu et al. ([@B16])   4         NA                             NA                                        M, RB, C, AP          NA                         T, L, Su, Sc                       Remission (4)

  Ertem et al. ([@B6])          2         Mean: 12.5 ± 1.5               2--6 years                                RB, RP, C             U                          L, Su, St, R                       Relapse (2)

  Gabra et al. ([@B9])          3         Median: 2.5 (Range: 2--15)     1--2 years                                S, RB                 U                          F, Sur                             Remission (2)\
                                                                                                                                                                                                       Relapse (1)

  de Carpi et al. ([@B19])      3         Mean: 11 ± 2.1                 NA                                        RB                    NA                         NA                                 NA

  Somani et al. ([@B20])        24        NA                             Mean: 12.6 ± 4.6 months                   RB                    U                          BT, L, APC                         Remission (24)

  Suresh et al. ([@B7])         22        Median: 10 (1.5--18 y)         Mean: 6 months                            RB, M, C, RP          E, U, Po                   T, F, Su, M                        Remission (14)\
                                                                                                                                                                                                       Relapse (8)

  Blackburn et al. ([@B17])     8         Mean: 9.87                     Mean: 1.73 yrs (Range:1 m−7 yrs)          S, RB, C, M           U, E                       T, L                               \
                                                                                                                                                                                                       Remission (4)\
                                                                                                                                                                                                       Relapse (2)\
                                                                                                                                                                                                       Lost to follow up(2)

  Perito et al. ([@B12])        15        Median: 13.9 (IQR 9.8--15.6)   Median: 3.2 (IQR 1.2--5.5) yrs            RB, D, C              E, U, Po                   L, M                               Lost to follow up (6)\
                                                                                                                                                                                                       Response (6)\
                                                                                                                                                                                                       Relapse (3)

  Urganci et al. ([@B11])       6         Median:13 (IQR 12--14)         Median: 1 yr (IQR 0.25--4)                C, D, RB, RP          U & Po                     Me, St, Sc                         Remission (6)

  Dehghani et al. ([@B14])      55        Mean: 10.4 ± 3.7               Mean: 15.5 ± 11.2 months                  RB, C, M, T, D        E, U, Po                   F, Su, Sc, St, R                   Lost to follow up (12)\
                                                                                                                                                                                                       Remission (30)\
                                                                                                                                                                                                       Not in remission (13)

  Anjum et al. ([@B21])         21        8--12                          NA                                        M, C, T               E, U, Po                   NA                                 NA

  Kowalska et al. ([@B13])      31        13 (Range: 5--18)              1--48 months                              RB, M, AP             U                          T,F, L, Me, Su, Sc, BT, APC, Sur   Response (20)\
                                                                                                                                                                                                       Failure (11)

  Podder et al. ([@B15])        140       Median: 12 (IQR 10--14)        Median: 21 (IQR 9--36) months             RB, C, S, D, RP, T    U                          T, BT, Local therapy               Lost to follow up (27)\
                                                                                                                                                                                                       Remission (71)

  Present study                 24        Median: 8 (IQR 5.75--11)       Median: 5.5 (IQR 3--6) months             RB, M, C, RP, D, AP   U, Po                      T, L, St                           Remission (23)\
                                                                                                                                                                                                       Lost to follow up (1)
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*N, number of children; NA, source not available*.

*RB, rectal bleeding; RP, rectal prolapse; M, mucorrhea; S, straining; C, constipation; D, diarrhea; T, tenesmus; AP, abdominal pain*.

*U, ulcer; Po, polypoidal lesion; E, erythema; T, toilet training; F, fiber; L, laxatives; Me, mesalamine tab; St, corticosteroid enema; Sc, sucralfate enema; Su, sulfasalazine enema; Inj.St, injection corticosteroid; R, rectoplexy; BT, bio-feedback training; APC, argon plasma coagulation; Sur, surgery*.

The next work-up was sigmoidoscopy with biopsy to rule out IBD. Endoscopic findings suggestive of SRUS were discrete well-demarcated single or multiple ulcers/erythema in contrast to continuous, symmetrical erythema/hyperemia mucosa with/without ulceration, and loss of vascular pattern in ulcerative colitis. Typical histological findings were fibrous obliteration of the lamina propria, streaming of fibroblasts, and muscle fibers between crypts, thickening or hyperplasia of muscularis mucosa, branching, and distorted glandular crypts, surface ulceration with minimal inflammation ([@B7]). Thus, diagnosis was ascertained by combination of clinical symptoms, colonoscopic findings, and histological examination.

Treatment was not standarized and various medicationas and surgical procedures had been tried ([@B22], [@B23]). Response to treatment was not consistent in the reviewed cases series ([Table 3](#T3){ref-type="table"}). Treatment should include reassurance of the patient and parents that the lesion is benign and chronic. High-fiber diet and appropriate toilet training in young and biofeedback therapy ([@B24]) in adolescents had shown encouraging results. Sucralfate enema may be effective in some patients ([@B25]) Sulfasalazine ([@B26]) and corticosteroids ([@B8], [@B11]) had been tried with varying response. Other treatment modalities include endoscopic application of human fibrin sealant ([@B27]), laser therapy ([@B28]), argon plasma coagulation ([@B20]). In contrast to other case series, we had observed remission in 75% of children with conventional treatment of laxative along with toilet training and only 25% needed rectal corticosteroid enema to achieve remission. Traditional squatting position for defecation and fiber rich staple food intake practices in our region may be a reason for achieving high remission by conventional treatment.

On reviewing case series published over past 20 years ([Table 3](#T3){ref-type="table"}), the major difference we observed in our present study was that early diagnosis and treatment by conventional methods itself achieve remission and decreases the morbidities due to SRUS in significant proportion.

Conclusion {#s5}
==========

We conclude that conventional treatments itself induce and maintain remission in most of SRUS patients if treatment is instituted at the earliest. Hence, early suspicion and diagnosis of SRUS must be considered in a child with bleeding per rectum.
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